Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome
The dual-specificity tyrosine-phosphorylation-regulated kinase, DYRK1B, is expressed de novo during myogenesis, amplified or mutated in certain cancers and mutated in familial cases of metabolic syndrome. DYRK1B is activated by cis auto-phosphorylation on tyrosine-273 (Y273) within the activation lo...
Main Authors: | Ashford, Anne L., Dunkley, Tom P. J., Cockerill, Mark, Rowlinson, Rachel A., Baak, Lisa M., Gallo, Raffaella, Balmanno, Kathryn, Goodwin, Louise M., Ward, Richard A., Lochhead, Pamela A., Guichard, Sylvie, Hudson, Kevin, Cook, Simon J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer International Publishing
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735261/ |
Similar Items
-
Mirk/dyrk1B Kinase in Ovarian Cancer
by: Friedman, Eileen
Published: (2013) -
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR
by: Deng, Xiaobing, et al.
Published: (2014) -
Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
by: Esti Wahyu Widowati, et al.
Published: (2018-05-01) -
DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome
by: Najas, Sònia, et al.
Published: (2015) -
Acridone alkaloids from Glycosmis chlorosperma as DYRK1A inhibitors
by: Beniddir, M.A.A., et al.
Published: (2014)